ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO528

25(OH)D3 Alone Stimulates Expression of 1,25(OH)2D3-Responsive Genes, Calbindin-D9K, and Megalin in mpkDCT Cells Where the Cyp27b1 Gene Was Deleted by CRISPR-Cas9

Session Information

Category: Bone and Mineral Metabolism

  • 401 Bone and Mineral Metabolism: Basic

Authors

  • Kikuyama, Takahiro, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
  • Susa, Takao, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
  • Tamamori-Adachi, Mimi, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
  • Iizuka, Masayoshi, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
  • Uchida, Shunya, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
  • Okazaki, Tomoki, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
  • Shibata, Shigeru, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
Background

During vitamin D synthesis, 25(OH)D3 (25D3) is converted to the active form, 1,25(OH)2D3 (1,25D3), by CYP27B1 in the proximal tubule of the kidney, then the latter exerts its function via vitamin D3 receptor (VDR). In the kidney, the 1,25D3-VDR axis is responsible for the increase in calcium reabsorption. Recently, it has been reported that 25D3 has bioactivity in certain tissues derived from Cyp27b1 knockout mice. On the other hand, others reported that 25D3-fed Cyp27b1 knockout mice produced normal level of 1,25D3 in the plasma. Such 1,25D3 might have been brought about by the other unknown enzyme(s) and it would be difficult to prove the direct cell-intrinsic activity of 25D3 (but not 1,25D3) using the Cyp27b1 knockout mouse models.

Methods

We used CRISPR-Cas9 system to knock out Cyp27b1 gene in the mouse kidney distal tubule cell line, mpkDCT cells. We then investigated the 25D3 function in these cells.

Results

Cyp27b1 knockout mpkDCT cells did not produce any measurable 1,25D3 after 25D3 administration to the cells. We found that 10-7 M of 25D3 translocated VDR into the nucleus and promoted expression of the positive control Cyp24a1 gene in the Cyp27b1 knockout mpkDCT cells. Microarray analysis also revealed that the exhaustive target gene profiles of 25D3 showed results similar to those of 1,25D3. Subsequently, we confirmed that 25D3 induced the expression of calcium reabsorption-related genes, Calbindin D9K (S100g) and Megalin (Lrp2), in the way analogous to 1,25D3.

Conclusion

In this study, we showed that a high dose(s) of 25D3 exerted vitamin D3 activity directly in the kidney cells without the aid of CYP27B1 function. We surmise that the ability to induce VDR target genes may provide a novel benefit with 25D3 in certain tissues. In the case of decreased CYP27B1 activity in advanced CKD, high concentrations of 25D3 may have a promising effect to maintain the serum calcium level.